These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16009920)

  • 1. PFO management: neurologists vs cardiologists.
    Messé SR; Cucchiara B; Luciano J; Kasner SE
    Neurology; 2005 Jul; 65(1):172-3. PubMed ID: 16009920
    [No Abstract]   [Full Text] [Related]  

  • 2. PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: the imperative of completing randomized controlled trials.
    Kaplan AV; Lukovits TG; Robb JF
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):6-8. PubMed ID: 17173274
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the ESPRIT results end the antiplatelet battle between neurologists and cardiologists?
    Albers GW
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):118-9. PubMed ID: 17330124
    [No Abstract]   [Full Text] [Related]  

  • 4. Choosing treatment for a PFO-related neurologic event.
    Romanic BM; Wolfe W
    JAAPA; 2000 Mar; 13(3):89-90, 93. PubMed ID: 11503406
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent foramen ovale management: who should do what?
    Rigatelli G; Cardaioli P
    Eur J Neurol; 2007 Mar; 14(3):341-2. PubMed ID: 17355558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent foramen ovale and cerebrovascular diseases.
    Desai AJ; Fuller CJ; Jesurum JT; Reisman M
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):446-55. PubMed ID: 16874357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale and stroke risk: incidental finding or causal culprit?
    Thomas CE
    Semin Neurol; 2005 Dec; 25(4):371-5. PubMed ID: 16341993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On horse sense and horse feathers: an argument against insistence on enrolling cryptogenic stroke patients with patent foramen ovale in randomized clinical trials.
    Kramer P
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):1-3. PubMed ID: 17173276
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transcatheter closure of patent foramen ovale.
    Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA
    Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefit of early anticoagulation in cardioembolic stroke.
    Micheli S; Agnelli G; Caso V; Paciaroni M
    Cerebrovasc Dis; 2008; 25(4):289-96. PubMed ID: 18303246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.
    Felberg RA
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):4-5. PubMed ID: 17173277
    [No Abstract]   [Full Text] [Related]  

  • 14. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study: closure of a patent foramen ovale without surgery following stroke.
    Duff D
    Axone; 2007; 28(2):42-3. PubMed ID: 17460958
    [No Abstract]   [Full Text] [Related]  

  • 16. Is PFO sizing necessary?
    Kern MJ
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):469; author reply 470-1. PubMed ID: 17721985
    [No Abstract]   [Full Text] [Related]  

  • 17. Stroke: a cardiologist's perspective.
    Bogart DB
    Mo Med; 2004; 101(5):503-9; quiz 509-10. PubMed ID: 15535028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indication to occlusion of patent foramen ovale in patient with pulmonary hypertension after a cardioembolic stroke].
    Svobodová I; Belohlávek J; Grünfeldová H; Linhart A
    Cas Lek Cesk; 2007; 146(4):407-10. PubMed ID: 17491252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale: current pathology, pathophysiology, and clinical status.
    Hara H; Virmani R; Ladich E; Mackey-Bojack S; Titus J; Reisman M; Gray W; Nakamura M; Mooney M; Poulose A; Schwartz RS
    J Am Coll Cardiol; 2005 Nov; 46(9):1768-76. PubMed ID: 16256883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.